Document is current
Any future updates will be listed below
-
Authors
Manning, James E. https://orcid.org/0000-0002-4240-659X
Ciantar, Etienne
Griffin, Morag
Kelly, Richard J.
- License Information
-
More Information
Article History
Received: 8 October 2024
Accepted: 2 April 2025
First Online: 17 April 2025
Declarations
:
: Not applicable.
: JM and EC have no conflicts of interest to declare. MG is on the advisory board of Amgen, Alexion, Novartis and Biocryst, has received lecture fees/honoraria from Alexion, Sobi and Regeneron, has undertaken consultancy for Regeneron and Biocryst and sat on advisory boards for Sobi.RK has received research funding from Sobi and Novartis, sat on advisory boards for Alexion, Jazz, Novartis and Sobi, received lecture fees/honoraria from Abbvie, Alexion, Astellas, Jazz, Novartis and Sobi and undertaken consultancy for Otsuka and Sobi.
